Tracked deals
5993
5993 tracked deals across 2007-2026.
Tracked deals
5993
5993 tracked deals across 2007-2026.
Buyer mix
Mixed buyer set
4741 strategic · 3177 pe
Top trend
Volume peaked in 2022
1005 tracked deals announced in 2022.
Primary Insight
Build a buyer list for your Healthcare Services deal
Find buyers actively acquiring healthcare services companies.
Find buyers like these for your dealBuyer Snapshot
Illustrative buyers pulled from tracked transactions on this page. This table is capped and intentionally non-exhaustive.
| Buyer | # Deals | Focus | Type |
|---|---|---|---|
| NMS Capital | 63 | Private equity firm focused on lower middle market invest... | PE |
| Gryphon Investors | 28 | Middle-market private equity firm and sponsor; provides c... | PE |
| The Riverside Company | 27 | Global private equity firm focused on the smaller end of ... | PE |
| Revelstoke Capital Partners | 26 | Healthcare-focused private equity firm that partners with... | PE |
| Sheridan Capital Partners | 23 | Chicago-based healthcare private equity firm focused on l... | PE |
| HCAP Partners | 22 | Southern California-based private equity and mezzanine de... | PE |
| BayMark Health Services | 21 | Operator of medication-assisted treatment (MAT) and behav... | Strategic (PE-backed) |
| H.I.G. Capital | 21 | Global alternative investment firm providing equity and d... | PE |
| InTandem Capital Partners | 21 | Private equity firm focused on investing in and growing h... | PE |
| Linden Capital Partners | 21 | Healthcare-focused private equity firm investing in middl... | PE |
Last 10 years
Supporting Data
Fiduciary Services Group (FSG), the parent company of DWC – The 401(k) Experts, acquired Pension Investors Corporation, a Florida-based third-party administrator (TPA). The deal expands FSG’s retirement plan administration platform and strengthens its footprint in Florida and the Southeast by integrating Pension Investors’ operations into FSG’s TPA business, DWC.
An affiliate of Peak Rock Capital completed its acquisition of Asembia LLC and its related entities. Asembia provides end-to-end technology-enabled commercialization solutions to the specialty pharma industry, including patient support HUB services, specialty distribution, data services, pharmacy software, and GPO solutions.
Trilogy Laboratories announced the acquisition of YNS Cosmeceuticals, a skincare brand known for its simple daily “Power Trio” system. Trilogy said the deal combines YNS’s skincare philosophy with Trilogy’s pharmaceutical formulation expertise, physician leadership, and FDA-registered manufacturing capabilities to support YNS’s next stage of growth.
Momentum Life Sciences announced a strategic growth investment from Parthenon Capital. Financial terms were not disclosed, and Momentum’s existing leadership team will remain significant shareholders. The investment is intended to accelerate Momentum’s growth and support planned strategic acquisitions across the specialty-therapy commercialization ecosystem.
Select Medical Holdings announced the completion of its acquisition by an entity affiliated with a consortium led by Robert A. Ortenzio, Martin F. Jackson, and Welsh, Carson, Anderson & Stowe (WCAS). The transaction values Select Medical at approximately $3.9 billion and was made effective July 1, 2026, with Select Medical’s stock ceasing to trade.
Headlands Research acquired Clinical Trials Research (CTR), a privately owned clinical research organization with sites in Sacramento and Lincoln, California. The acquired sites will operate as Headlands Research – Sacramento and Headlands Research – CTR Lincoln, expanding Headlands’ California footprint and strengthening its cardiometabolic therapeutic area capabilities. Financial terms were not disclosed.
Empower entered into a definitive agreement to acquire Milliman's retirement administration business in a transaction valued at $340 million. The deal is expected to close in the second half of 2026, pending customary regulatory approvals and closing conditions.
Experity, an on-demand healthcare technology platform for U.S. urgent care clinics, announced it has acquired Exdion Healthcare, an AI-driven chart-to-cash revenue cycle management (RCM) SaaS platform. The acquisition is intended to unify clinical, operational, and financial workflows with AI to accelerate reimbursement, reduce manual work, and improve denials and payment velocity. Exdion’s insurance-focused affiliate is excluded from the transaction and will continue to operate independently.
SteriMax Inc. acquired Andone Pharmaceuticals Inc., a Canadian pharmaceutical and medical device company based in Oakville, Ontario. The deal strengthens SteriMax’s injectable business while expanding its platform into medical device and veterinary markets, with Andone founder Jay Barat joining SteriMax to lead those new businesses.
SilverCape Investments released an open letter to PetMed Express’s board urging the company to engage with a revised proposal to acquire all outstanding shares for $3.00 per share in cash. The offer represents a ~70% premium to PetMed’s June 26, 2026 closing price and, according to SilverCape, has no financing contingency.
AMR Clinical (AMR), an integrated multi-site clinical research company, acquired ClinOhio Research Services, a multi-therapeutic clinical research site based in Columbus, Ohio. The acquisition expands AMR’s geographic presence and strengthens capabilities in Dermatology, Women’s Health, and Gastroenterology.
Ipsen entered into a definitive merger agreement to acquire Kartos Therapeutics. The deal will add navtemadlin, a late-stage oral MDM2 inhibitor in Phase III, to Ipsen’s hemato-oncology pipeline.
Davion Healthcare Plc has entered into a share purchase agreement to acquire 100% of Humaskan Ltd for total consideration of $60 million, consisting of $10 million in cash and $50 million in Davion shares. The company also plans to establish a wholly owned UK subsidiary, Davion Healthcare Finance Ltd, to support its acquisition program via a proposed corporate bond program of up to £100 million.
H.B. Fuller (NYSE: FUL) announced a recommended cash offer to acquire Advanced Medical Solutions Group plc (LSE: AMS) for an implied enterprise value of about £715 million. Under the terms, eligible AMS shareholders will receive £2.85 per share in cash, and the deal is expected to close by the end of calendar year subject to approvals and customary conditions.
Boundless and Merakey USA announced a strategic affiliation to create a shared national framework for delivering “whole-person, whole-life care” for people with autism, mental health conditions, substance use disorders, and intellectual/developmental disabilities. Under the affiliation, Boundless will continue operating under its established name while connecting to Merakey’s broader platform and capabilities.
Merck KGaA entered into a definitive agreement to acquire Bio-Techne for $73 per share in cash, valuing the deal at about $11.3 billion (€9.9 billion). The acquisition is intended to strengthen Merck KGaA’s position across fast-growing life-sciences markets by adding Bio-Techne’s multi-omics, analytical technologies, and integrated workflow solutions.
DUOS, a “performance infrastructure for health plans,” announced it has acquired Linkwell Health to strengthen its end-to-end platform from enrollment through care completion and health outcomes. The acquisition deepens DUOS’ AI-powered activation layer and expands its footprint to more than 20 health plans nationwide.
ChartSpan completed its acquisition of Validic, a personal health data platform focused on wearable and clinical device data integration. The combined company operates as ChartSpan, combining ChartSpan’s care management services with Validic’s remote patient monitoring and health data API/infrastructure to enable continuous patient visibility and proactive clinical action.
DermDox Group announced the acquisition of Modern Aesthetics Plastic Surgery, an aesthetic medicine and plastic surgery practice serving patients across Pennsylvania. The deal expands DermDox’s integrated dermatology, aesthetic medicine, and plastic surgery capabilities and adds multiple Mid-Atlantic locations under Modern Aesthetics’ name and leadership of Dr. Robert Skalicky.
Model N announced it has acquired Kalderos, a technology company that provides a gross-to-net intelligence platform for visibility into the 340B drug discount program. The acquisition is intended to expand Model N’s revenue management capabilities and strengthen its 340B offerings for pharmaceutical manufacturers through Kalderos’ Truzo platform.
Arthur J. Gallagher & Co. has acquired Cincinnati Benefit Solutions, LLC, an Ohio-based employee benefits services firm focused on small businesses in Cincinnati and nearby areas. Drew Locaputo and the Cincinnati Benefit Solutions team will remain in their current location under the direction of Brian Lomas, head of Gallagher’s Great Lakes region employee benefits consulting and brokerage operations. Financial terms were not disclosed.
Integrated Water Services (IWS) acquired Tetrasolv Filtration to expand advanced water treatment, specialized filtration/media services, rentals, and field support capabilities. The deal, which closed on June 22, 2026, positions the combined organization to deliver turnkey wastewater treatment solutions for industrial and municipal mid-market customers.
EBI, an Avista Healthcare Partners portfolio company, announced the acquisition of Xstim, a division of Precision Medical Products Inc. Xstim develops a next-generation, wearable, non-invasive spine fusion electrical stimulation therapy intended to support lumbar spinal fusion and related bone-healing applications.
Belmont Medical Technologies acquired Arcos, Inc., a Missouri City, Texas-based health IT company focused on trauma, burn care, and Massive Transfusion Protocol (MTP) workflow software. The acquisition expands Belmont’s life-saving medical technology portfolio by combining Arcos’s Burn Navigator and BloodNav solutions with Belmont’s Rapid Infuser systems.
LeadingReach acquired iNaira Healthcare Technologies to bring EHR integration and automation capabilities in-house. The acquisition supports LeadingReach’s AI-powered “Intelligent Automation Services,” including fax automation, chart creation, and appointment sync that feed structured referrals directly into providers’ EHRs.
IM Cannabis Corp. entered into a non-binding letter of intent to sell its European-focused assets to Slil.com Holding Ltd. The transaction is structured as Slil purchasing IM Cannabis’ wholly owned subsidiary, I.M.C. Holdings Ltd., which will primarily hold the company’s European operations, including Adjupharm GmbH in Germany, and certain API and branded interests.
Align Capital Partners-backed Premier Biotech announced the acquisitions of NexScreen and TransMed to expand its product portfolio, e-commerce capabilities, and global footprint. NexScreen adds point-of-care diagnostic testing presence in Australia and New Zealand, while TransMed strengthens Premier’s catalog and online distribution to 1,000+ direct customer accounts.
Simulations Plus, Inc. has entered into a definitive agreement to be acquired by affiliates of Altaris in an all-cash transaction valued at approximately $375 million. The deal is expected to combine Simulations Plus with Altaris portfolio company Chemical Computing Group (CCG) and is currently expected to close in Q4 2026, subject to customary approvals.
Abarca Health and LucyRx announced a strategic combination to create an independent pharmacy benefit manager (PBM) designed to serve commercial and government clients at scale. The combined company will provide prescription services to more than 9 million members and will operate the Abarca and LucyRx brands as wholly owned subsidiaries of Healthcare Revolution Partners at closing, expected in Q3 2026.
Compliancy Group acquired Healthicity, a provider of healthcare compliance and healthcare auditing software, to create a unified platform for healthcare compliance and auditing. The combined organization will serve more than 3,000 healthcare organizations across the U.S. and select global markets, combining workforce compliance, risk assessment, third-party risk, incident management, and provider/coding/documentation auditing capabilities.
WPS announced its acquisition of Mavida Health, a digital mental health company providing clinical care and community support for women and families across the reproductive journey. The deal expands WPS’s digital healthcare capabilities, with plans to pursue licensure expansion into Wisconsin and evaluate additional member offerings.
Thurston Group, a Chicago-based private equity firm, announced the formation of a national dental support platform by uniting SGA Dental Partners, Gen4 Dental Partners, and Modis Dental Partners under the SGA Dental Partners brand. The combined platform will serve 250+ locations and 500+ dentists across 26 states, combining doctor recruiting, professional development, and implant/specialty support capabilities.
UpRight Science acquired Highmark’s FDA-cleared balance assessment application to bring objective, precise balance measurement into routine clinical care. The technology is intended to help providers measure balance, track changes over time, and intervene before falls occur.
Singlepoint Healthcare announced its acquisition of Healix, a national provider of outpatient infusion management services based in Sugar Land, Texas. The deal expands Singlepoint’s multi-specialty inflammatory disease care platform by adding Healix’s capabilities across more than 220 physician-owned and ambulatory infusion centers in the U.S.
Pelago Bioscience, a cell-based target engagement contract research organization (CRO), has acquired RG Discovery to create an integrated drug discovery platform spanning biology and medicinal chemistry. The combination is intended to support customers across the full DMTA (design-make-test-analyze) cycle with a single specialist partner, reducing workflow handoffs from hit identification through lead optimization.
Humana entered into a definitive agreement to divest all or substantially all of its minority interest in Gentiva, an end-of-life care provider. The agreement values Humana’s minority stake at approximately $900 million, with proceeds intended for general corporate purposes; the transaction is expected to close in Q3 2026 subject to approvals.
Merck Animal Health has signed a definitive agreement to acquire TARGAN, a privately held animal-agriculture technology company focused on biodevice solutions for the poultry industry, for an undisclosed amount. The acquisition is expected to close in the third quarter of 2026, subject to regulatory approvals and customary closing conditions.
Pillr Health announced that it has acquired Cooper Strategy, a Jupiter, Florida-based company that helps covered entities capture savings from the federal 340B drug pricing program. The combined platform will offer expanded pharmacy solutions for hospitals, health systems, and community health centers, including contract pharmacy administration, split billing, compliance support, and pharmacy optimization.
PharmaEssentia Corporation announced it will acquire 100% of Canadian specialty pharmaceutical company FORUS Therapeutics Inc. in a transaction valued at US$36.5 million. The deal is intended to deepen PharmaEssentia’s presence in Canada’s hematology-oncology myeloproliferative neoplasm (MPN) market and accelerate commercialization of BESREMi (ropeginterferon alfa-2b) by integrating FORUS’s regulatory, medical, and commercial capabilities.
Sagility announced it is acquiring CareSeed, a U.S. healthcare analytics company focused on NCQA-certified HEDIS quality reporting and related chart abstraction and regulatory analytics for health plans. The deal is intended to expand Sagility’s AI-led healthcare quality and Stars capabilities and support health plans across the quality lifecycle, moving from retrospective HEDIS reporting toward prospective care gap closure and ongoing performance monitoring.
Merrithew International Inc. announced the acquisition of the GYROTONIC organization, creator of the GYROTONIC and GYROKINESIS movement methods. The deal is intended to strengthen Merrithew’s global leadership in mindful movement education, training, and equipment by expanding its education and programming portfolio.
PartsSource announced its acquisition of SkillNet, a workforce intelligence platform for healthcare technology management (HTM) that provides hospitals and health systems real-time visibility into technician competencies and team capabilities. The deal expands PartsSource’s Enterprise Clinical Technology platform by adding workforce intelligence to improve clinical capacity and help organizations close technician skill gaps.
Med-Metrix entered into a definitive agreement to acquire CanAide, a provider of Medicaid eligibility and enrollment services and RCM automation solutions. The deal aims to strengthen Med-Metrix’s end-to-end revenue cycle platform by extending front-end capabilities, improving patient access, and enhancing net revenue yield for health system clients.
Healthcare Holding Schweiz AG, a Swiss buy-build-technologize healthcare platform, has acquired Compet Medical AG. Compet Medical, headquartered in Schindellegi (Canton of Schwyz), supplies harm-reduction and hygiene-related products for low-threshold care settings across Switzerland and other European markets.
4DMedical announced an agreement to acquire Austrian AI-based software lung imaging company contextflow. The deal is intended to give 4DMedical an immediate commercial and clinical platform in Europe and expand its portfolio of AI-powered respiratory imaging solutions, including lung cancer screening and thoracic imaging.
Lewis & Clark Capital announced the formation of AirCore Environmental, an indoor air quality platform built through the acquisitions of Florida-based Radon Mitigation Services (RMS) and Radon Professional Services (RPS). The platform will initially focus on radon mitigation services for commercial customers across the Southeastern United States and is intended to serve as a foundation for additional complementary IAQ add-ons.
AMN Healthcare (through its AMN Language Services division) has acquired Jaide Health, an AI-enabled medical interpretation and translation platform. The deal is intended to expand AI-powered language access beyond clinical encounters, supporting patients and care teams across the broader healthcare journey. Financial terms were not disclosed.
International SOS Government Medical Services (INTL.SOS GMS) announced the acquisition of Federal Staffing Resources (FSR) from Epic Staffing Group. The deal is intended to expand INTL.SOS GMS’s healthcare staffing capabilities and better support federal, state, and local agencies across the U.S. and overseas.
Capsa Healthcare acquired The Harloff Company, a manufacturer of clinical storage cabinets, procedure carts, and medication storage products. The acquisition expands Capsa’s clinical care portfolio and strengthens its ability to deliver integrated, end-to-end solutions across healthcare settings.
ECLAT Health Solutions, a revenue cycle management, risk adjustment, and healthcare technology provider, completed a management buyout (MBO) from Gulf Capital. The transaction returns full ownership of ECLAT to its founders and management team after a five-year partnership in which the company scaled its workforce from about 450 to over 4,000 employees and grew revenue and EBITDA by roughly 10x.
Full Export
Get the full acquisitions list for this page as CSV + XLSX.
Find buyers actively acquiring healthcare services companies.
Common capability themes include healthcare technology management (HTM), IT spend management and cost optimization, workforce intelligence for technician competencies, healthcare analytics for quality reporting, and revenue cycle automation or pharmacy support.
No. The recent locations listed include the United States as well as Canada, Israel, Austria, and Switzerland.
No. For example, AMN Healthcare’s acquisition of Jaide Health notes that financial terms were not disclosed, while another deal (PharmaEssentia acquiring FORUS Therapeutics) states a transaction value.
Recurring buyer names shown include Serent Capital, KKR, Thurston Group, ARC Health, MBF Healthcare Partners II, L.P., Palm Medical Centers, and Crestline Investors, alongside company acquirers named in the recent events.